Risk-benefit analysis of Pfizer COVID vaccine in children 5 to 11 fails, shows at least 117 deaths to save one life

Share it with your friends Like

Thanks! Share it with your friends!

Close

The U.S. Food and Drug Administration’s risk-benefit assessment in connection with Pfizer’s application for emergency use of its COVID vaccine for children 5 to 11 describes only relative risks in an older population. It ignores absolute risk and also the standard calculation for measuring a drug’s effectiveness — Number Needed To Vaccinated (NNTV). …read more

Source: Sott health news feed

    

  • Rating:
  • Views:436 views
  • Categories: Health